Tuesday, June 16, 2026

New Fast-Charging Lithium Metal Battery Could Double Your EV’s Range

A research team has developed ultra-fast charging technology for lithium metal batteries, allowing full charge in just 12 minutes.

‘Do they still have Future?’: North Korea Celebrates 80 Years of the Workers’ Party

North Korea intensifies propaganda for the Workers' Party's 80th anniversary, emphasizing self-reliance and national defense amidst global challenges.

North Korea Slams U.S. Missile Shield as ‘Space Nuclear War Script’

North Korea criticizes the U.S. missile defense system Golden Dome, calling it a nuclear war plan, while emphasizing loyalty and ideology.

Tag: clinical trials

Exploring Cenobamate: How SK Biopharmaceuticals’ New Oral Suspension Benefits Adult Epilepsy Patients

SK Biopharmaceuticals submits NDA for Cenobamate oral suspension, enhancing treatment options for epilepsy patients with swallowing difficulties.

ABL Bio to Invest Additional $25 Million in Neok Bio to Accelerate ADC Clinical Trials

ABL Bio invests $25M in Neok Bio for bispecific antibody-drug conjugate trials, aiming for FDA-approved treatments by 2027.

Lunit and Selcarta Join Forces: Accelerating AI Biomarker Companion Diagnostics in 2026

Lunit partners with Selcarta to enhance AI-based biomarkers for diagnostics, aiming to streamline clinical trials and accelerate drug development.

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

FDA’s Game-Changing Guidelines: What Asian Biotech Firms Must Know About Clinical Trial Efficiency

Clinical Trial Design is crucial for success in pharma; FDA's new rules could ease burdens but raise quality standards.

How Samsung Medical Center is Revolutionizing Cancer Patient Care in Asia with EORTC Partnership

Samsung Medical Center's Cancer Hospital partners with EORTC to enhance cancer patients' quality of life through patient-reported outcomes.

Hyundai Bioscience Launches Global Clinical Trials for Dengue Treatment in Vietnam

Hyundai BioScience launches global clinical trials for a broad-spectrum antiviral treatment targeting dengue fever in Vietnam.

Emocog’s Cogthera is Revolutionizing MCI Treatment in 2026

Emocog develops innovative digital therapeutics for mild cognitive impairment, enhancing dementia care through early intervention and AI technology.

Unlocking Cancer Treatment: ABL206 and ABL209’s Promising Non-Clinical Data Revealed at AACR

ABL Bio will present preclinical data for its ADCs ABL206 and ABL209 at AACR 2023, showcasing promising anti-cancer efficacy.

Revolutionary CAR-T Treatment SynKIR-310 Outperforms CD19 CAR-T: What This Means for Blood Cancer Patients

Verismo Therapeutics' SynKIR-310 shows superior anti-tumor effects in preclinical studies, promising a safer CAR-T therapy for blood cancers.

Breakthrough Cancer Drug BAL0891: Key Findings to be Revealed at AACR 2026

SillaJen's cancer drug BAL0891 will be presented at the AACR 2026 conference, highlighting its effects on gastric and breast cancer models.

SK Bioscience Pours 4 Billion KRW into RSM01, Accelerating RSV Antibody Trials

SK Bioscience secures funding from the Light Foundation to support clinical trials for its RSV prevention monoclonal antibody RSM01.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

SleepQ vs. Traditional Medications: Which is the Future of Insomnia Treatment?

Welt aims to complete clinical trials for its SleepQ insomnia device by year-end, targeting listing on Germany's DiGA reimbursement system.

Top News

- Our Sponsors Ad -

Follow us